PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PAVmed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.25−0.16 (-6.64%)
Close on Oct 19, 2026
- Market cap
- $14.11M
- P/E (TTM)
- –
- Dividend yield
- –
PAVmed statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | PAVmed | Industry median |
|---|---|---|
| Market Cap | $17.99M | $230.55M |
| Enterprise Value | -$1.53M | $202.97M |
| PS Ratio | 160.63 | 3.11 |
| PB Ratio | 0.51 | 3.14 |
| P/TBV Ratio | 0.51 | 4.57 |
Enterprise value
| Measure | PAVmed | Industry median |
|---|---|---|
| EV / Sales | -13.70 | 2.92 |
Income (trailing twelve months)
| Measure | PAVmed | Industry median |
|---|---|---|
| Revenue | $112.00K | $102.39M |
| Gross Profit | -$247.00K | $60.36M |
| Operating Income | -$26.70M | -$4.31M |
| Pretax Income | -$16.43M | -$2.26M |
| Net Income | -$12.09M | -$6.57M |
| EBITDA | -$26.63M | -$1.98M |
Margins
| Measure | PAVmed | Industry median |
|---|---|---|
| Gross Margin | -220.5% | 55.1% |
| Operating Margin | -23842.9% | -6.04% |
| Pretax Margin | -14669.6% | -4.11% |
| Profit Margin | -10794.6% | -10.5% |
| EBITDA Margin | -23772.3% | -2.67% |
| FCF Margin | -6948.2% | -0.30% |
Returns
| Measure | PAVmed | Industry median |
|---|---|---|
| Return on Equity (ROE) | -33.3% | -19.2% |
| Return on Assets (ROA) | -28.7% | -13.3% |
| Return on Invested Capital (ROIC) | -65.1% | -4.11% |
| Return on Capital Employed (ROCE) | -73.9% | -9.07% |
Growth
| Measure | PAVmed | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -89.0% | 8.85% |
| Net Income Growth (YoY) | -116.6% | 10.6% |
| Revenue Growth (3Y CAGR) | -42.7% | 7.08% |
Balance sheet
| Measure | PAVmed | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.78M | $37.33M |
| Net Cash (Debt) | $3.78M | $3.92M |
| Net Cash Per Share | $0.47 | $0.28 |
| Equity (Book Value) | $35.05M | $57.36M |
| Book Value Per Share | $4.38 | $2.81 |
| Tangible Book Value | $35.05M | $10.71M |
| Working Capital | $770.00K | $54.64M |
Financial position
| Measure | PAVmed | Industry median |
|---|---|---|
| Current Ratio | 1.19 | 2.50 |
| Quick Ratio | 0.93 | 1.54 |
| Interest Coverage | -3338.00 | -1.81 |
Cash flow (trailing twelve months)
| Measure | PAVmed | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.73M | -$653.46K |
| Capital Expenditures | -$52.00K | -$3.69M |
| Free Cash Flow | -$7.78M | -$835.02K |
| FCF Per Share | -$0.97 | -$0.02 |
Efficiency
| Measure | PAVmed | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.59 |
| Revenue Per Employee | $37.33K | $322.57K |
| Profits Per Employee | -$4.03M | -$51.88K |
| Employee Count | 3 | 185 |
Dividends and yields
| Measure | PAVmed | Industry median |
|---|---|---|
| Earnings Yield | -67.2% | -6.91% |
| FCF Yield | -43.3% | -0.56% |
Shares
| Measure | PAVmed | Industry median |
|---|---|---|
| Shares Outstanding | 7,995,920 | 44,856,700 |
| Shares Change (YoY) | 125.7% | 3.35% |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 6,119,860 | 37,097,900 |
| Shares Held by Insiders | 23.5% | 10.6% |
| Shares Held by Institutions | 11.7% | 63.5% |
Scores
| Measure | PAVmed | Industry median |
|---|---|---|
| Altman Z-Score | -10.86 | 1.95 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | 25.04 | -2.64 |
Calculated by StockData from PAVmed's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.